
Defense mechanisms against cadmium toxicity. III. Effects of pretreatment with a small oral dose of cadmium on metallothionein synthesis after a large oral dose of cadmium in mice.
Author(s) -
Shigeru Morita
Publication year - 1984
Publication title -
japanese journal of pharmacology/japanese journal of pharmacology
Language(s) - English
Resource type - Journals
eISSN - 1347-3506
pISSN - 0021-5198
DOI - 10.1254/jjp.35.153
Subject(s) - metallothionein , cadmium , kidney , chemistry , toxicity , pharmacology , intestinal mucosa , medicine , endocrinology , biology , organic chemistry
Pretreatment of female mice with a small oral dose of Cd2+ (15 mg Cd2+/kg) decreased Cd2+ uptake by the liver and kidney and increased that by the small intestinal mucosa at 4 or 24 hr after challenge with a large oral dose of Cd2+ (100 mg Cd2+/kg). By 4 hr after the challenge dose, more Cd2+ taken up by the liver was bound to metallothionein (MT) in the Cd2+-pretreated mice than the water-pretreated controls (10 ml H2O/kg); but at 24 hr, the amount of Cd2+ bound to MT in the liver and kidney were lower in the former than the latter. The amount of Cd2+ not bound to MT in the liver at 4 and 24 hr after the challenge dose and that in the kidney at 24 hr were lower in the Cd2+-pretreated mice than the water-pretreated controls. These results suggested that the factor directly related to the toxic action of Cd2+ was the amount of Cd2+ not associated with MT in the liver and other organs. More Cd2+ taken up by the small intestinal mucosa at 24 hr after the challenge dose was associated with MT in the Cd2+-pretreated mice than the water-pretreated controls. The present study indicates that MT induced in the small intestinal mucosa by pretreatment prevents Cd2+ absorption by sequestering subsequently administered Cd2+, and Cd2+ taken up by the liver and kidney is bound to MT in an inert form, thus the decrease in the amount of Cd2+ not bound to MT, giving protection from the acute oral toxicity of the cation. Pretreatment 24 hr prior to the challenge dose was found to be the most effective.